Breakthroughs for Faster
Healing from our Company to You
In 2014, three tenured product executives founded CrossRoads Extremity Systems to launch breakthrough products for faster healing. They wanted to create a company based on their values and what they enjoyed most about being medical device engineers. Throughout their 20-plus year careers, their most rewarding experiences were working with surgeons to improve surgeries and help patients heal faster. This has become the core of CrossRoads.
We work with surgeons to develop breakthrough products that cannot be found anywhere else.
With over 40 combined years of experience in the high-tech medical device industry, our founders wanted their new company to embrace what they found to be the keys to success: ingenuity, integrity, hard work and service to community and family.
The name CrossRoads was chosen as a reminder of these American values that are deeply rooted in our company culture. We work tirelessly to demonstrate these ideals in our service to patients, surgeons, hospitals, sales partners and each other. Through our unwavering commitment to our core values, we have become the best in our industry at providing breakthrough products for faster healing.
We work with surgeons to develop breakthrough products for faster healing that cannot be found anywhere else
CEO and Co-Founder
Vernon and his wife Jennifer moved from Louisiana to Tennessee in 1996. Vernon is a life-long orthopedic professional. After completing his bachelor’s degree in Biomedical Engineering from Louisiana Tech, he joined Smith and Nephew Orthopedics as a product development engineer while simultaneously completing his masters degree in Biomechanical Engineering from the University of Tennessee. In 2000 he moved to Wright Medical Technology where he progressed through the ranks from engineer to Senior Director of Product Development. During his 9-year tenure at Wright, he oversaw the development of both reconstruction, upper extremity and foot and ankle products. Vernon then moved into the start-up company environment with senior leadership roles at two companies before he, Glen Coleman and Chad Hollis founded CrossRoads in 2014. Vernon currently resides in Collierville, TN with his wife and 4 children.
Why CrossRoads is Different:
“Different is built into our company DNA – starting with the individual people working here all the way to the CrossRoads operating room experience. We think and act different because our company is filled with passionate people who continue to strive to always perform better – we don’t settle for being the best.”
VP R&D and Co-Founder
After graduating with a mechanical engineering degree from the University of Tennessee, Chad began his engineering career in consumer goods. After six years, Chad moved to Wright Medical Technology where he worked as a development engineer for reconstruction and extremities and had various roles of increasing responsibility. He then moved to engineering management for IMDS and Biomimedica until cofounding CrossRoads.
Why CrossRoads is Different:
“Our speed of innovation development is unparalleled in the industry. We can react quickly if we, or one of our customers, have a concept for a device or technique that will improve patient outcomes. This allows us to constantly stay at the forefront of technology.”
Chairman, Healthpoint Capital
Mike is the President and Managing Director of Healthpoint Capital. Prior to Healthpoint, Mike was President, Chief Executive Offcer and Director of DJO Global, a $1 billion firm in the Orthopedic sector owned by Blackstone. DJO was the fastest growing firm in Total Joint implants and Consumer Sports Medicine under his leadership. Prior to joining DJO, Mike served as Group President, Orthopaedics for Stryker Corp. managing Stryker’s global orthopaedic businesses, which represented approximately $3 billion in revenue. Additionally, in his 22 years in the musculoskeletal space at Stryker, Mike served as Managing Director of all of Stryker’s divisional segments in Germany, Austria and Switzerland.
John H. Foster
John is a 37-year veteran of private equity investing and a successful entrepreneur and executive. He founded Foster Management Company in 1972, which managed seven private equity funds. Additionally, he was founder and CEO of most of Foster Management’s portfolio companies including Foster Medical Corporation and NovaCare, Inc. He is Healthpoint Capital’s specialist on China: Trustee of the Asia Fund, Asian Cultural Council and a Founder/Advisory Board Member of the Asia Society Policy Institute. He was formerly a Board Member of Avon, Inc. and Corning Incorporated, a Trustee of the Asia Society, the Hospital for Special Surgery in New York, the Burke Rehabilitation Hospital, and the Children’s Hospital of Philadelphia, on the Dean’s Council at the Harvard School of Public Health, and an Overseer of the Amos Tuck School of Business Administration.
Prior to joining Healthpoint Capital, Milen Todorov was a Director in the global healthcare team at UBS Investment Bank, focusing on the musculoskeletal sector. While at UBS, Milen executed over 25 M&A and capital raising transactions with aggregate value in excess of $35 billion. He began his career in economic litigation consulting at Charles River Associates.
MB Venture Partners
Gary co-founded MB Venture Partners in 2001 after six years in healthcare investment banking and research. He also spent seven years in a variety of general management roles with Abbott Laboratories, one of the largest and most diversified healthcare companies in the world. He is a certified public accountant and a chartered financial analyst. Gary is a board member or observer for several MBVP portfolio companies and also serves on the board of Life Science Tennessee and ZeroTo510.
It’s actually very simple:
We care. We work hard. We do and think differently.
If you’re a surgeon, patient, or prospective sales partner, you should get to know us because our products really do help patients heal faster.
We are dedicated to creating believers in CrossRoads by:
Delivering on the promise of faster healing for patients.
Improving the operating room experience
Developing breakthrough products and services
Promoting responsibility, sustainability, and sound ethics
Serving others with passion and urgency
Treating others with integrity, dignity, and respect regardless of circumstances
Complex problems require different thinking and breakthrough solutions
Commitment to the pursuit of excellence in every area of our business
CrossRoads Extremity Systems® (CRE) is committed to conducting its affairs in compliance with all applicable laws and regulations, and with the highest ethical standards. We established this Code of Conduct to ensure CRE meets our commitment to ethical and lawful conduct. This Code of Conduct applies to all employees, officers, and directors of CRE, as well as contractors, consultants and distributors who provide services on CRE’s behalf.
This Code of Conduct establishes policies and procedures intended to guide employees, officers, directors, contractors, consultants, and distributors in the performance of their duties and responsibilities and ensure compliance with CRE’s commitment to ethical and lawful conduct.
Advanced Medical Technology Association
The Advanced Medical Technology Association (AdvaMed) is dedicated to the advancement of medical science and the improvement of patient care. In particular, AdvaMed believes that high quality, cost-effective health care technology can make toward achieving those goals. AdvaMed members recognize adherence to ethical standards and compliance with applicable laws are critical to the medical device industry’s ability to continue its collaboration with healthcare professionals. Members encourage ethical business practices and socially responsible industry conduct related to their interactions with healthcare professionals.
Members also respect the obligation of healthcare professionals to make independent decisions regarding Member products. Consequently, AdvaMed adopted this voluntary Code of Ethics, effective January 1, 2004, and revised and restated with an effective date of July 1, 2009, to facilitate Members’ ethical interactions with those individuals or entities that purchase, lease, recommend, use, arrange for the purchase or lease of, or prescribe Members’ medical technology products in the United States.
Without reservation, CrossRoads Extremity Systems® strongly endorses both the letter and spirit of the AdvaMed Code of Ethics.
California Declaration of Compliance Program
Declaration of Adoption of Comprehensive Compliance Program Pursuant to California Health and Safety Code Section 119402 CrossRoads Extremity Systems®, LLC. (“CRE”) is in the business of designing, manufacturing, and selling orthopedic medical devices. As a medical device manufacturer, CRE has developed a comprehensive compliance program that is specific to the nature of the business as a medical device manufacturer and consistent with the United States Department of Health and Human Services Office of Inspector General Compliance Program Guidance for Pharmaceutical Manufacturers. The purpose of our compliance program is to prevent and detect violations of law or company policy. Our compliance program is based upon the principles set forth in the Advanced Medical Technology Association Code of Ethics on Interactions with Healthcare Professionals (AdvaMed Code) and the Company’s Code of Business Conduct. The AdvaMed Code is substantially equivalent to
the Pharmaceutical Research and Manufacturers of America Code on Interactions with Healthcare Professionals (PhRMA Code) but reflects the unique interactions between medical technology companies and health care professionals. CRE Code of Business Conduct is our statement of ethical and compliance principles that guide our daily operations and articulates our fundamental principles, values, and framework for action within our organization. Additional compliance guidance is communicated through our Compliance Manual for the U.S. which applies to interactions with healthcare professionals to the extent that they provide services or medical technologies in the United States. This guidance establishes explicit limits on gifts, promotional material or items, or activities that CRE or its representatives may provide to an individual healthcare professional. CRE declares that to the best of its knowledge, CRE complies with the provisions of California Health and Safety Code Section 119402 as of November 10, 2011.
Use the contact form to let us know how we can help you!
6055 Primacy Parkway, Suite 140
Memphis, Tennessee 38119
Phone: (901) 221-8406